Portfolio & Decision Analysis and the Fight Against Antimicrobial Resistance
Jon Mauer, Pfizer
June 17, 2015 (SDP Webinar - Invited Talk)
solutions had been proposed by stakeholders from professional groups, academia
and government to reinvigorate antibiotic drug development and address the
emerging threat of infection posed by drug-resistant pathogens. This
presentation illustrates how decision analysis clarified what solutions would
address the problems most effectively and aligned stakeholders to rally support
for specific changes in public policy that would have the most impact towards
stimulating antibiotic development. President Obama signed the Generating
Antibiotic Incentives Now Act (i.e., GAIN Act) into law to help create a robust
and sustainable antibacterial research and development infrastructure and early
signs show it is having the desired effect.
Click on the file below to hear a sample of the presentation.